ClinConnect ClinConnect Logo
Search / Trial NCT06458101

Efficacy and Safety of Ureteroscopic Lithotripsy (Including Flexible Ureteroscopy) Without Indwelling Urinary Catheter

Launched by SHANGHAI GENERAL HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Jun 9, 2024

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to treating kidney stones using a procedure called ureteroscopic lithotripsy, which breaks up stones in the urinary tract. The researchers want to find out if patients can safely go home without a urinary catheter, which is a tube that helps drain urine from the bladder. The trial will compare two groups of patients: those who have the ureteroscopic procedure with a catheter and those who do not, focusing on their pain levels and how urgently they need to urinate after the procedure.

To participate in this trial, patients should be between 18 and 70 years old and have normal kidney function. They must be undergoing a specific type of surgery to remove kidney stones, but certain health issues like severe heart or lung diseases, or past surgeries that affect the urinary system, may prevent them from joining. Participants can expect close monitoring of their recovery and will help researchers understand if avoiding a catheter can reduce discomfort after surgery. This trial is currently not recruiting participants, but it aims to provide important insights into improving care for kidney stone patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with upper urinary tract calculi undergoing rigid ureteroscopic and soft ureteroscopic lithotripsy;
  • Normal renal function;
  • Aged between 18 and 70 years old
  • Complete the operation under general anesthesia
  • Exclusion Criteria:
  • Solitary kidney;
  • Previous history of renal transplantation or urinary diversion;
  • Congenital malformation of urinary system;
  • Abnormal coagulation mechanism due to blood system diseases, liver diseases, etc.
  • Severe heart or lung disease, Malignant tumor and immunodeficiency state
  • Urethral stricture
  • Neurogenic bladder
  • Operation under epidural anesthesia or spinal anesthesia
  • Large amount of bleeding during operation should be observed by indwelling catheter to observe urine color
  • High risk factors such as large amount of pus fur should be observed during operation.
  • Urethral injury during operation leads to false passage
  • Operation time is more than 90 minutes. Higher risk of bleeding or infection

About Shanghai General Hospital, Shanghai Jiao Tong University School Of Medicine

Shanghai General Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in various medical specialties to conduct rigorous and ethical trials aimed at improving patient outcomes. With a focus on collaboration and scientific integrity, Shanghai General Hospital plays a pivotal role in the development of new therapies and interventions, contributing significantly to the global healthcare landscape.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported